相关实验视频
Updated: Jan 14, 2026

08:02
In Vivo Augmentation of Gut-Homing Regulatory T Cell Induction
Published on: January 22, 2020
5.9K
尿素二酸葡萄糖6-脱酶介导的葡萄糖化及其在肠肝免疫调节中的新兴作用
Ye-Qiu Yang1, Ning Li2, Shuai Liu1
1Department of Cardiology, The First People's Hospital of Jiashan, Jiaxing 314100, Zhejiang Province, China.
World journal of gastrointestinal oncology
|October 20, 2025
概括
尿素二酸葡萄糖6脱酶 (UGDH) 通过影响肠道免疫力和屏障功能来促进肝癌. 向UGDH可能会恢复免疫平衡并减缓癌症的进展,特别是在代谢性肝细胞癌 (HCC) 中.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 免疫学 免疫学 免疫学
- 代谢研究的研究.
背景情况:
- 尿素二酸葡萄糖6脱酶 (UGDH) 被确定为肝细胞癌 (HCC) 中的一种亲瘤性酶.
- UGDH对葡萄糖化至关重要,影响瘤生长和HCC微环境的免疫抑制状态.
研究的目的:
- 探索UGDH在肠肝轴内的更广泛影响.
- 提出UGDH在通过排毒和维持肠道屏障完整性来调节免疫调中的作用.
- 研究肠道微生物群和肝脏代谢中的UGDH之间的双向反循环.
主要方法:
- 对UGDH,肠肝轴和肝细胞癌现有研究的审查和整合.
- 分析UGDH在代谢途径,免疫调节和肠道屏障功能中的作用.
- 探索UGDH,肠道微生物群代谢物和免疫逃生机制之间的联系.
主要成果:
- UGDH失调可能会影响葡萄糖化,导致胆酸积累,增加肠道透性和微生物转移.
- 肠道微生物群的代谢物可以调节肝脏UGDH的表达,从而创建一个反循环.
- UGDH可能起到代谢免疫检查点的作用,将代谢功能障碍与免疫逃脱联系起来.
结论:
- 准UGDH是一种恢复肠肝免疫平衡的潜在策略.
- 调节UGDH可能有助于延缓胃肠道癌症的进展,特别是在代谢性HCC.
- UGDH整合了代谢,微生物和免疫因素,为HCC治疗提供了一个新的转化框架.
相关概念视频
Phase II Reactions: Glucuronidation
1.6K
Glucuronidation, a pivotal phase II biotransformation process, involves the coupling of glucuronic acid to a drug or xenobiotic. Given its widespread occurrence and critical role in drug metabolism, it's considered the most crucial phase II reaction. It enhances the water solubility of substances, aiding their expulsion from the body. The driving force behind these reactions is a group of enzymes known as UDP-glucuronosyltransferases (UGTs). UGTs facilitate the transfer of a glucuronic acid...
1.6K
Biosynthesis of Polysaccharides
548
Polysaccharides such as glycogen and starch are synthesized from nucleoside diphosphate sugars, primarily uridine diphosphate glucose (UDPG) and adenosine diphosphate glucose (ADPG). These activated glucose donors act as key intermediates in carbohydrate metabolism and biosynthesis. UDPG primarily involves glycogen synthesis in animals and many bacteria, while ADPG plays a fundamental role in starch synthesis in plants and certain bacteria.UDPG is formed when glucose-1-phosphate reacts with...
548
Drug Metabolism: Phase II Reactions
4.9K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
4.9K
Glucose Absorption Into the Small Intestine
35.0K
Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and...
35.0K
Glucose Transporters
27.2K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
27.2K
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
817
Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
817

